Goldenwell Biotech GWLL Growth Metrics (2020-2026)

OTC GWLL
$0.69 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT
Reported Financials

Goldenwell Biotech Quarterly Growth Metrics

Periods 26 quarters
Latest Jun 2026

Goldenwell Biotech reported asset growth of -89.16% for the quarter ended Jun 2026. These growth metrics cover 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
93.92%85.45%-29.07%-46.11%-45.23%-46.11%-28.92%-29.91%-29.74%-8.17%-9.32%4.19%-4.01%-1.71%-3.54%33.39%30.28%-83.89%-90.23%-89.16%
Assets Growth (3y)
0.24%-9.30%-2.82%-22.96%-26.72%-28.25%-21.36%-14.65%-0.87%-4.22%-47.41%-55.95%-46.79%
Assets Growth (5y)
-1.89%-1.38%-32.01%-46.68%-43.63%
Assets (QoQ)
-4.58%-5.12%-33.04%-11.11%-3.03%-6.64%-11.67%-12.34%-2.81%22.02%-12.77%0.72%-10.46%24.95%-14.40%39.29%-12.55%-84.55%-48.08%54.52%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
-7.03%-14.09%-14.09%-82.54%-75.06%-78.46%-79.36%-60.04%-79.48%15.73%-45.05%50.15%-60.11%-7.19%-29.29%197.46%859.45%-45.80%-21.68%-85.44%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
-42.86%-44.04%-59.16%-63.76%-40.17%-53.98%-52.85%-72.67%-38.61%-56.88%21.30%-7.74%-16.50%-32.74%-13.35%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
-27.50%-41.57%-21.18%-28.87%-35.96%-44.23%-46.12%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-5.10%-8.32%0.00%-79.93%35.51%-20.81%-4.18%-61.13%-30.41%346.57%-54.50%6.19%-81.51%938.99%-65.33%346.70%-40.37%-41.31%-49.90%-16.93%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-1,324.37%-551.19%3.03%83.33%221.72%-4,633.86%78.08%-7.62%-331.31%97.92%9.12%-77.21%40.46%-32.89%-11.26%224.35%-47.32%25.65%58.60%-179.61%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-634.86%-139.31%-474.65%-242.29%-85.78%42.20%31.75%-18.79%-9.38%39.49%63.51%-59.12%72.61%25.20%-20.61%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-61.45%-69.18%234.72%-103.82%-44.66%38.36%20.64%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
91.67%-54.91%-651.85%82.81%160.80%-6,124.77%96.52%15.59%-30.67%45.82%-52.08%-64.60%56.10%-20.92%-27.32%283.98%-152.01%38.97%29.11%-253.80%
EBIT Growth (1y)
-9,935.41%-3,264.19%-171.26%-207.16%94.83%-818.01%-0.66%-1.06%-672.38%97.74%13.84%-76.56%40.79%-21.89%-25.83%41.03%-23.04%9.69%14.00%-23.32%
EBIT Growth (3y)
-1,052.63%-142.42%-470.32%-242.14%-91.11%-37.82%-57.57%38.17%36.76%-2.96%-1.71%-77.87%70.81%2.31%-8.69%
EBIT Growth (5y)
-111.36%-72.89%-186.54%-96.34%-50.35%-21.69%-27.66%
EBIT Margin Growth (1y)
-0.30M0.07M0.60M-0.91M-0.93M-2.46M
EBIT Margin Growth (3y)
-3.67M
EBIT Margin (QoQ)
-0.30M-0.13M-0.64M0.77M0.07M-0.74M0.05M0.13M
EBIT (QoQ)
-454.71%-13.01%66.70%19.73%82.90%-19,977.05%96.35%19.41%-30.73%41.26%-39.22%-65.15%56.16%-20.93%-43.72%22.60%8.53%11.24%-36.86%-10.98%
EBT Growth (1y)
-1,937.78%-891.74%28.74%-12.38%74.55%-3,014.07%-0.66%-1.06%-672.38%97.74%7.59%-84.32%34.86%-31.99%-10.69%39.30%-20.94%8.95%2.74%-14.77%
EBT Growth (3y)
-1,052.63%-142.42%-470.32%-242.14%-91.11%12.81%-27.92%-8.59%2.43%-0.98%-4.18%-82.57%69.94%0.17%-8.69%
EBT Growth (5y)
-114.75%-70.89%-190.68%-99.44%-53.01%6.52%-7.84%
EBT Margin Growth (1y)
0.14M0.01M0.60M-0.91M-0.93M-2.61M
EBT Margin Growth (3y)
-3.38M
EBT Margin (QoQ)
0.20M-0.05M-0.78M0.77M0.07M-0.74M0.05M0.13M
EBT (QoQ)
24.46%-64.06%-12.97%19.73%82.90%-19,977.05%96.35%19.41%-30.73%41.26%-49.31%-60.74%53.80%-19.02%-25.23%11.86%7.94%10.40%-33.77%-4.01%
EPS (Basic) Growth (1y)
-1,669.58%-780.29%27.59%-13.64%74.18%-2,850.32%4.66%4.30%-631.44%97.74%7.59%-84.32%34.86%-31.99%-24.09%39.30%-20.94%-627.60%54.31%-21.70%
EPS (Basic) Growth (3y)
-1,210.61%-127.78%-435.89%-222.09%-80.38%13.91%-26.09%-7.15%4.17%-3.02%-2.30%-79.28%39.90%19.39%-10.84%
EPS (Basic) Growth (5y)
-131.96%-68.42%-180.02%-92.34%-123.98%18.41%-8.17%
EPS (Basic) (QoQ)
24.71%-66.37%-13.00%19.71%82.90%-18,912.94%96.35%19.41%-30.73%41.26%-49.31%-60.74%53.80%-19.02%-40.38%21.37%7.94%-616.04%91.19%-109.45%
EPS (Diluted) Growth (1y)
-31.99%-24.09%39.30%-20.94%-627.60%54.31%-18.55%
EPS (Diluted) (QoQ)
-49.31%-65.02%53.80%-15.93%-40.38%19.28%7.94%-597.48%91.19%-109.45%
FCF Margin Growth (1y)
1.29M0.01M3.44M-0.91M-0.93M-2.46M
FCF Margin Growth (3y)
-2.08M
FCF Margin (QoQ)
1.35M-0.03M-3.63M3.60M0.07M-0.75M0.05M0.19M
Free Cash Flow Growth (1y)FCF Growth (1y)
-1,324.37%-551.19%3.03%83.33%221.72%-4,633.86%78.08%-7.62%-331.31%97.92%9.12%-77.21%40.46%-32.89%-11.26%224.35%-47.32%25.65%58.60%-179.61%
Free Cash Flow Growth (3y)FCF Growth (3y)
-634.86%-139.31%-474.65%-242.29%-85.78%42.20%31.75%-18.79%-9.38%39.49%63.51%-59.12%72.61%25.20%-20.61%
Free Cash Flow Growth (5y)FCF Growth (5y)
-61.45%-69.18%234.72%-103.82%-44.66%38.36%20.64%
Free Cash Flow (QoQ)FCF (QoQ)
91.67%-54.91%-651.85%82.81%160.80%-6,124.77%96.52%15.59%-30.67%45.82%-52.08%-64.60%56.10%-20.92%-27.32%283.98%-152.01%38.97%29.11%-253.80%
Gross Margin Growth (1y)
1.0018.00-264.00-255.00-402.0036.00
Gross Margin Growth (3y)
-217.00
Gross Margin (QoQ)
0.00M1.0011.00-10.0016.000.00M-131.00-0.00M
Gross Profit Growth (1y)
235.80%260.32%240.19%-92.93%-99.19%-49.28%
Gross Profit Growth (3y)
-50.61%
Gross Profit (QoQ)
1,000.00%-59.66%-91.89%833.49%1,080.32%-80.59%34.78%-60.75%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
-25.83%41.03%-23.04%9.69%14.00%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
-65.15%56.16%-20.93%-43.72%22.60%8.53%11.24%-36.86%
Net Cash Flow Growth (1y)NCF Growth (1y)
-1,324.37%-880.91%-831.02%-225.66%221.72%-4,633.86%98.68%-7.62%-134.23%104.50%-1,410.15%105.56%-302.40%8.08%-11.26%3,861.31%-47.32%-142.21%58.60%-103.82%
Net Cash Flow Growth (3y)NCF Growth (3y)
-78.83%-33.63%-474.65%-81.04%184.05%-51.19%-57.78%-18.79%62.67%39.49%63.51%-59.12%72.61%-90.88%56.16%
Net Cash Flow Growth (5y)NCF Growth (5y)
-28.95%-53.39%234.72%-103.82%-57.01%-21.71%-16.15%
Net Cash Flow (QoQ)NCF (QoQ)
-162.77%-54.91%-651.85%82.81%160.80%-6,124.77%99.79%-1,302.71%80.67%892.94%-170.22%105.17%-1,498.60%312.97%-172.29%283.98%-152.01%38.97%29.11%83.00%
Net Income Growth (1y)
-1,937.78%-891.74%27.59%-12.38%74.55%-3,014.07%-0.68%-1.06%-672.38%97.74%7.59%-84.32%34.86%-31.99%-24.09%39.30%-20.94%8.95%54.31%-14.77%
Net Income Growth (3y)
-1,052.63%-142.42%-470.32%-242.14%-91.11%12.34%-27.92%-8.59%2.43%-4.90%-4.18%-82.57%69.94%19.39%-8.69%
Net Income Growth (5y)
-114.75%-74.83%-190.68%-99.44%-53.01%17.51%-7.84%
Net Income (QoQ)
24.46%-64.06%-12.95%19.71%82.90%-19,977.05%96.35%19.41%-30.73%41.26%-49.31%-60.74%53.80%-19.02%-40.38%21.37%7.94%10.40%29.56%-97.52%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-1,920.02%-892.97%27.59%-13.64%74.18%-3,015.44%-0.68%-1.06%-672.38%97.74%7.59%-84.32%34.86%-31.99%-24.09%39.30%-20.94%-627.60%54.31%-21.70%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-1,317.69%-142.42%-470.32%-242.79%-91.21%12.34%-28.40%-9.11%2.42%-4.90%-4.18%-82.57%39.90%19.39%-10.84%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-143.15%-74.83%-190.68%-99.67%-131.95%17.51%-9.35%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
24.71%-66.37%-13.00%19.71%82.90%-19,977.05%96.35%19.41%-30.73%41.26%-49.31%-60.74%53.80%-19.02%-40.38%21.37%7.94%-616.04%91.19%-109.45%
Net Margin Growth (1y)
0.14M0.01M0.60M-0.91M-0.93M-2.61M
Net Margin Growth (3y)
-3.38M
Net Margin (QoQ)
0.20M-0.05M-0.78M0.77M0.07M-0.74M0.05M0.13M
Operating Income Growth (1y)Op. Inc Growth (1y)
-9,935.41%-3,264.19%-171.26%-207.16%94.83%-818.01%-0.66%-1.06%-672.38%97.74%13.84%-76.56%40.79%-21.89%-25.83%41.03%-23.04%9.69%14.00%-23.32%
Operating Income Growth (3y)Op. Inc Growth (3y)
-1,052.63%-142.42%-242.14%-91.11%-37.82%-57.57%38.17%36.76%-2.96%-1.71%-77.87%70.81%2.31%-8.69%
Operating Income Growth (5y)Op. Inc Growth (5y)
-111.36%-72.89%-96.34%-50.35%-21.69%-27.66%
Operating Income (QoQ)Op. Inc (QoQ)
-454.71%-13.01%66.70%19.73%82.90%-19,977.05%96.35%19.41%-30.73%41.26%-39.22%-65.15%56.16%-20.93%-43.72%22.60%8.53%11.24%-36.86%-10.98%
Operating Margin Growth (1y)
-0.30M0.07M0.60M-0.91M-0.93M-2.46M
Operating Margin Growth (3y)
-3.67M
Operating Margin (QoQ)
-0.30M-0.13M-0.64M0.77M0.07M-0.74M0.05M0.13M
Profit After Tax Growth (1y)PAT Growth (1y)
-1,937.78%-891.74%28.74%-12.38%74.55%-3,014.07%-0.66%-1.06%-672.38%97.74%7.59%-84.32%34.86%-31.99%-10.69%39.30%-20.94%8.95%2.74%-14.77%
Profit After Tax Growth (3y)PAT Growth (3y)
-1,052.63%-142.42%-470.32%-242.14%-91.11%12.81%-27.92%-8.59%2.43%-0.98%-4.18%-82.57%69.94%0.17%-8.69%
Profit After Tax Growth (5y)PAT Growth (5y)
-114.75%-70.89%-190.68%-99.44%-53.01%6.52%-7.84%
Profit After Tax (QoQ)PAT (QoQ)
24.46%-64.06%-12.97%19.73%82.90%-19,977.05%96.35%19.41%-30.73%41.26%-49.31%-60.74%53.80%-19.02%-25.23%11.86%7.94%10.40%-33.77%-4.01%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-0.00M-0.00M-0.00M-0.00M-0.04M-0.04M-0.04M-0.05M0.03M0.04M0.04M0.05M-882.00-0.00M0.00M0.00M-0.00M-0.03M-0.04M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.01M-0.00M-0.01M-0.00M-0.00M-0.00M-0.00M-0.00M0.03M0.01M0.00M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
-0.01M-0.04M-0.04M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-265.00-654.00-241.00-973.00206.00-0.03M-0.00M-0.01M-0.01M0.05M278.00-0.00M296.0058.00-164.000.00M241.00-0.00M-0.03M-0.01M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-0.01M-0.03M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-0.00M385.00-943.00
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-0.00M-0.00M-0.00M0.00M0.00M-0.03M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
-0.00M-0.00M-0.00M-0.00M-0.00M-0.04M-0.05M-0.06M-0.08M0.03M0.04M0.02M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
-0.08M-0.01M-0.02M-0.05M
Return on Equity [ROE] (QoQ)ROE (QoQ)
-628.00-0.00M36.00-550.00284.00-0.04M-0.01M-0.01M-0.02M0.07M-0.00M-0.03M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-0.30M0.07M-0.00M0.60M-0.91M-0.93M-0.59M-0.99M-2.46M-2.04M-8.06M-8.17M4.69M-10.28M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-3.67M-2.90M-8.65M-8.55M-3.96M-19.44M-19.89M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
-21.10M
Return on Sales [ROS] (QoQ)ROS (QoQ)
-0.30M-0.13M-0.64M0.77M0.07M-0.21M-0.03M-0.74M0.05M0.13M-0.42M-2.22M0.47M-5.88M-0.54M-15.51M-1.20M
Revenue Growth (1y)
235.71%259.12%258.19%-92.57%-99.13%-49.64%
Revenue Growth (3y)
-49.91%
Revenue (QoQ)
1,000.00%-59.67%-91.91%835.26%1,076.68%-80.59%38.41%-31.94%

Goldenwell Biotech Growth Metrics API

Pull Goldenwell Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GWLL&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY